Related Experiment Video
Updated: May 20, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC.
Volker Steger1, Stefanie Veit, Tobias Walker
1Clinic of Thoracic, Cardiac and Vascular Surgery, Tübingen University, Tübingen, Germany.
The Thoracic and Cardiovascular Surgeon
|July 24, 2012
Summary
This study compared two neoadjuvant chemotherapy protocols for stage III non-small cell lung cancer (NSCLC). Protocol 2 showed a significant downstaging effect, suggesting more intensive treatment may improve outcomes in trimodal therapy.
Area of Science:
- Thoracic Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Neoadjuvant chemotherapy intensification in stage III non-small cell lung cancer (NSCLC) has been explored in trimodal settings.
- Direct comparisons of intensified protocols are limited by varying selection criteria and institutional experience.
Purpose of the Study:
- To compare the efficacy of two distinct neoadjuvant chemotherapy protocols in a trimodal setting for stage III NSCLC.
- To evaluate survival, recurrence rates, and downstaging effects between the protocols.
Main Methods:
- Single-center retrospective study involving 159 patients with stage III NSCLC.
- Analysis of survival, recurrence, and tumor downstaging (ypTNM) following two different neoadjuvant protocols.
- Statistical analysis using Log-rank test and Cox regression.
Main Results:
- Overall median survival was 32 months; Protocol 1: 26 months, Protocol 2: 35 months.
- Protocol 2 demonstrated a significant downstaging effect on N-stage and overall UICC stage.
- pN-stage and ypUICC-stage were significant predictors of survival.
Conclusions:
- An intensified neoadjuvant protocol (Protocol 2) showed a trend towards improved survival and a significant downstaging benefit in stage III NSCLC.
- Achieving R0 resection with Protocol 2 is associated with better downstaging outcomes.
- Dose intensity in neoadjuvant therapy appears crucial for improving treatment efficacy in trimodal settings.
Related Concept Videos
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:15Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...